Da Vinci Robot Surgical Risks Detailed
Da Vinci surgical robots have become ubiquitous in U.S. hospitals, with about 1,500 now operating just in the United States. But their rapid adoption has raised questions about whether they are really superior to other surgical methods such as laparotomy or an open surgery.
They are expensive, costing an estimated $3.5 million over a five-year period. And their comparative effectiveness over other surgical procedures has not been well documented.
In a January report, the ECRI Institute noted that in the midst of the growth of these devices, "questions remain about clinician learning curves, what the ideal training program is, how many procedures are needed to maintain proficiency and what criteria hospitals should use to credential surgeons using these systems."
Proponents of robotic surgery state that the benefits this technology offers, including improved visualization, precision, and dexterity for the surgeon, make these systems well worth the added cost incurred to implement and maintain them," the ECRI report said.
"While this may be true, the real unanswered questions are how much value they add and, more importantly, how and when will they definitively improve patient care and long-term outcomes?"
Cheryl Clark is senior quality editor and California correspondent for HealthLeaders Media. She is a member of the Association of Health Care Journalists.
- EHR Systems 'Immature, Costly,' AMA Says
- Better HCAHPS Scores Protect Revenue
- Narrow Networks Cut Costs, Not Quality, Economists Say
- Anthem Blue Cross, 7 CA Health Systems Create New Challenger, Business Model
- Interstate Medical Licensure Effort Advances
- CEO Exchange: Preparing for Population Health
- 'Early Offer' Malpractice Programs May Spur Reform
- How to Build a Health Plan from Scratch
- Data Points to Boom in Private HIX
- 3 Strategies for Retaining Millennial Employees